Please login to the form below

Not currently logged in

Pfizer to provide free drugs to unemployed

Pfizer will provide free medication to Americans and their families who have recently been made unemployed and have lost their health insurance

Pfizer has said it will provide free medication to Americans and their families who have recently been made unemployed and have therefore lost their health insurance.

The programme, which will ensure patients who were already taking the company's medications continue to have access to treatment, is available to Americans who have become unemployed since the start of January 2009, regardless of their previous income. Citizens enrolled on the programme will be eligible for free access to treatment for up to a year.

"We all know people who have been laid off recently and have lost their health insurance, making it difficult for them to pay for healthcare," said Dr Jorge Puente, Pfizer's regional president of Worldwide Pharmaceuticals. "We thought there must be some way we could help recently unemployed people who are taking Pfizer medicines to continue treatment during these challenging economic times."

The idea for the programme (known as MAINTAIN) was suggested by Pfizer employees, who will also take part in the programme by donating their own money. The Pfizer foundation will match any donations from employees.

14th May 2009


Featured jobs

Subscribe to our email news alerts


Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...